Omnicell (OMCL) EPS (Diluted) Growth (3y) (2013 - 2026)
Powered by 
Analysis
Omnicell (OMCL) EPS (Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -12.16% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 24.56% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 24.50% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 19.81% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 50.83% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -6.12% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 33.46% |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 19.01% |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 90.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90.49% |
| Mar 31, 2026 | 39.94% |
| Dec 31, 2025 | 58.67% |
| Sep 30, 2025 | -31.24% |
| Jun 30, 2025 | -15.09% |
| Mar 31, 2025 | -42.27% |
| Dec 31, 2024 | 5.51% |
| Sep 30, 2024 | -32.58% |
| Jun 30, 2024 | -42.80% |
| Mar 31, 2024 | -46.15% |
| Dec 31, 2023 | -41.77% |
| Sep 30, 2023 | -15.45% |
| Jun 30, 2023 | 40.15% |
| Mar 31, 2023 | -48.69% |
| Dec 31, 2022 | -47.41% |
| Sep 30, 2022 | -7.61% |
| Jun 30, 2022 | -19.23% |
| Mar 31, 2022 | 30.19% |
| Dec 31, 2021 | -7.19% |
| Sep 30, 2021 | 22.06% |